Lessee, Operating Lease, Liability, to be Paid, Year Three of FibroBiologics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: FibroBiologics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
FibroBiologics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2025 was $347,000, a 32% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

FibroBiologics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$347,000	-$162,000	-32%	31 Dec 2025	10-K	24 Feb 2026	2025	FY
Q3 2025	$440,000			30 Sep 2025	10-Q	31 Oct 2025	2025	Q3
Q2 2025	$576,000	+$67,000	+13%	30 Jun 2025	10-Q	31 Jul 2025	2025	Q2
Q4 2024	$509,000	-$35,000	-6.4%	31 Dec 2024	10-K	31 Mar 2025	2024	FY
Q2 2024	$509,000			30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$509,000			31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$544,000			31 Dec 2023	10-K	29 Feb 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.